linorion 2,5 mg kapsułki twarde
orion corporation - lenalidomidum - kapsułki twarde - 2,5 mg
linorion 25 mg kapsułki twarde
orion corporation - lenalidomidum - kapsułki twarde - 25 mg
linorion 20 mg kapsułki twarde
orion corporation - lenalidomidum - kapsułki twarde - 20 mg
linorion 15 mg kapsułki twarde
orion corporation - lenalidomidum - kapsułki twarde - 15 mg
linorion 10 mg kapsułki twarde
orion corporation - lenalidomidum - kapsułki twarde - 10 mg
linorion 7,5 mg kapsułki twarde
orion corporation - lenalidomidum - kapsułki twarde - 7,5 mg
linorion 5 mg kapsułki twarde
orion corporation - lenalidomidum - kapsułki twarde - 5 mg
nicotine perrigo 4 mg tabletki do ssania
wrafton laboratories limited - nicotinum - tabletki do ssania - 4 mg
nicotine perrigo 2 mg tabletki do ssania
wrafton laboratories limited - nicotinum - tabletki do ssania - 2 mg
kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - inne środki przeciwnowotworowe - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.